Come up with a name for your new list and we'll add to it:
CytoPherx raised a round of funding on June 06, 2009. Investors include
Qualifying Therapeutic Discovery Project.
CytoPherx, formerly Nephrion, is a clinical stage medical device company addressing inflammation based diseases and conditions with a selective cytopheresis-based inflammation modulating system.…